Natural product-derived therapy for Human Leukemias: Casuarinin, a hydrolyzable tannin isolated from the bark of Terminalia arjuna Linn. (Combretaceae), suppresses B-Cell and myeloid leukemias via up regulation of the tumor suppressor IRF4, 4/February/2017, 7.20 am

Anti-telomerase cancer therapy: Gastrokine-1 suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) and the cellular immortality gene telomerase and inhibits cancer progression via down-regulation of it target gene, 4/February/2017, 6.33 am
February 4, 2017
Natural product-based therapy for Metastatic tumors: Formononetin, an isoflavone found in the roots of astragalus membranaceus, Trifolium pratense, Glycyrrhiza glabra, and Pueraria lobata, increases the expression of tumor suppressor gene BTG2 and inhibits invasion, migration and metastasis of tumor cells via down regulation of its target gene, 4/February/2017, 4.07 pm
February 4, 2017
Show all

Introduction: What they say

Noble laureate in Physiology/Medicine (1975) Prof. David Baltimore, from California Institute of Technology, California, USA, had reported in the July 8, 2014 issue of the Journal “Blood” that: “Dual mechanisms by which MiR-125b represses IRF4 to induce myeloid/B-cell leukemias.” 


What we say:

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-derived therapy for Human Leukemias: Casuarinin, a hydrolyzable tannin isolated from the bark of Terminalia arjuna Linn. (Combretaceae), suppresses B-Cell and myeloid leukemias via up regulation of the tumor suppressor IRF4


From Research findings to Therapeutic opportunity:

This study suggests that Casuarinin, by increasing the expression of  its target gene, it may increase the expression of a number of tumor suppressor genes, including IRF4. Thereby, it could inhibit the progression of B-Cell and myeloid leukemias (fig. 1).

price-100

[easy_payment currency=”USD”]

Taken together, this study suggests that pharmacological formulations encompassing       Casuarinin or its analogues or Casuarinin in combination with other anticancer drugs may be used to inhibit B-Cell and myeloid leukemias.

Casuarinin inhibits IRf4 expression

Figure 1 Mechanistic insight into how Casuarinin, isolated from Terminalia Arjuna,  increases the expression of IRF4 to prevent cancer proliferation


Details of the research details

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How Manumycin A increases the expression of IRF4?

Amount: $ 100

For purchase and payment details, you may reach us at admin@genomediscovery.org

# Research cooperation


References:

Web: http://genomediscovery.org or newbioideas.com/

CitationBoominathan, L., Natural product-derived therapy for Human Leukemias: Casuarinin, a hydrolyzable tannin isolated from the bark of Terminalia arjuna Linn. (Combretaceae), suppresses B-Cell and myeloid leukemias via up regulation of the tumor suppressor IRF4, 4/February/2017, 7.20 am,  Genome-2-Bio-Medicine Discovery Center.

Courtesy: When you cite drop us a line at admin@genomediscovery.org

Comments are closed.